FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/07/2026
Voltar para busca
Dado oficial do USPTO
AB ANALITICA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AB ANALITICA
ST13
US500000079399168Classe
5, 42
Pedido
79399168
Registro
8054659
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
23/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
21/03/2024
Data de registro
09/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
23/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IT
Examinador
LOBO, DEBORAH E
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
AB ANALITICA S.r.l.
Representantes
Robert S. Broder Collard & Roe, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Gastrointestinal treatment preparations; medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; milk sugar for pharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations and substances for medical purposes; clinical medical reagents; clinical diagnostic reagents for medical use; diagnostic agents for medical use; diagnostic substances for medical use; diagnostic agents for pharmaceutical use; biological indicators for medical diagnosis; pregnancy testing preparations; in vitro diagnostic preparations for medical use; chemical reagents for in-vitro veterinary purposes for use by veterinary laboratories; chemical reagents for in-vitro medical purposes for use by medical laboratories; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical compounds for treating cancer; male fertility test kits; reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; chemical reagents for medical use; reagents for use with analyzers for medical purposes; diagnostic chemical reagents for medical use; reagents for use in analysis for medical purposes; chemical test reagents for medical purposes; diagnostic biomarker reagents for medical purposes; reagents for use in diagnostic tests for medical purposes; reagents for microbiological analysis for medical purposes; chemical reagents for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in diagnostic tests for veterinary purposes; reagents for analytical purposes for medical purposes; medical diagnostic reagents and assays for testing of body fluids; reagents for use in diagnostic pregnancy tests; reagents for use in analysis for veterinary purposes; culture media for medical use; reagents for use in veterinary genetic testing; biochemical preparations for medical use; preparations for detecting mutation in prion genes for medical purposes; preparations for detecting genetic predispositions for medical purposes; glucose for medical purposes; glucose dietary supplements; glucose for use as an additive to foods for medical purposes; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating gastrointestinal disorders; antivirals in the nature of DNA synthesis inhibitors; chemical preparations for use in DNA analysis for medical purposes; dietary supplements and dietetic preparations; diagnostic preparations for medical or veterinary purposes.
Classe 42
Pharmaceutical drug development services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical and pharmacological research services; medical research laboratory services; testing of pharmaceuticals; research and development of vaccines and medicines; design and development of medical diagnostic apparatus; scientific research for medical purposes in the area of cancerous diseases; research and development in the field of diagnostic preparations; genetic research; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; laboratory research in the field of gene expression; DNA screening for scientific research purposes; laboratory research servicesDNA testing services to determine paternity; testing for new product development; design and testing for new product development; testing of new product designs for others; new product design; quality control for others; design and testing for new product development; design and testing of new products; scientific research and development; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; scientific research and development services; research and development of computer software; development and testing of chemical production methods; quality control of manufactured goods; design and development of computer hardware; software design and development; design of instruments; design services relating to data processing tools; design and development of diagnostic apparatus; product research and development; computer design research; development of pharmaceutical preparations and medicines; scientific investigations for medical purposes; biological researchclinical research and medical research; research in the field of pharmacogenetics; laboratory testing of materials; laboratory services for medical research; research and development in the field of microorganisms and cells; research relating to molecular sciences; research and development in the field of biotechnology; bacteriological research; toxicology testing for research purposes; biological research and analysis; physics research; chemical research; scientific research relating to biology; biological research laboratory services; research and development services in the field of immunohistology; provision of medical research services; leasing of scientific laboratory research instruments; computer rental; software developmentprogramming and implementation; data mining; computer software design and updating; preparation of technical reports in the pharmaceutical field; preparation of scientific reports in the pharmaceutical field; technological research in the pharmaceutical field; scientific analysis in the field of molecular biology; biological research.
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/07/2026
FIMP
FINAL DISPOSITION PROCESSED
03/07/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/03/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/10/2025
PUBO
PUBLISHED FOR OPPOSITION
21/10/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/09/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
22/09/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/09/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
22/09/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/09/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2025
GNRT
NON-FINAL ACTION E-MAILED
09/03/2025
CNRT
NON-FINAL ACTION WRITTEN
09/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2025
RFNT
REFUSAL PROCESSED BY IB
02/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/10/2024
RFRR
REFUSAL PROCESSED BY MPU
11/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/10/2024
CNRT
NON-FINAL ACTION WRITTEN
08/10/2024
DOCK
ASSIGNED TO EXAMINER
28/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/07/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/07/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/07/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AB ANALITICA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.